The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
A Randomized Clinical Trial Investigating the Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
National Defense Medical Center, Taiwan
212,000 participants
Aug 1, 2025
INTERVENTIONAL
Conditions
Summary
This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.
Eligibility
Inclusion Criteria2
- Patients in the emergency department
- Patients received at least 1 ECG examination.
Exclusion Criteria2
- The patients received ECG at the period of inactive AI-ECG system.
- Patients with a history of coronary angiography within the past 3 days.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The AI-ECG system will conduct a real-time analysis of the ECG. When the system identifies potential OMI cases, it will immediately send short message service notifications to the on-duty cardiologists. This will enable the cardiologists to promptly review and confirm the diagnosis.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06887699